Patrick M. Dillon
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 16
- Cancer Treatment and Pharmacology 13
- HER2/EGFR in Cancer Research 9
- Cancer Diagnosis and Treatment 5
- Aging top 10%
- Immunology top 10%
- Biological Psychiatry top 10%
- Cancer Research top 10%
-
- Advanced Breast Cancer Therapies 10
- Brain Metastases and Treatment 8
-
- Palliative Care and End-of-Life Issues 6
-
- Monoclonal and Polyclonal Antibodies Research 6
- Co-authors
- Christopher A. MoskalukChristopher Y. ThomasAnne M. MillsErik DillSamhita ChakrabortyTimothy N. J. BullockNorman E. SharplessK. Lenhard Rudolph
- Cited by
- OncologyAgingImmunology
- Journals
- Journal of Clinical Oncology (13 papers)Medical Oncology (4 papers)Clinical Cancer Research (3 papers)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Patrick M. Dillon
79 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Oncology 1.2k
- Aging 38
- Immunology 389
- Biological Psychiatry 45
- Cancer Research 247
Countries citing papers authored by Patrick M. Dillon
This map shows the geographic impact of Patrick M. Dillon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick M. Dillon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick M. Dillon more than expected).
Fields of papers citing papers by Patrick M. Dillon
This network shows the impact of papers produced by Patrick M. Dillon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick M. Dillon. The network helps show where Patrick M. Dillon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Patrick M. Dillon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 9 | |
| 3 | 2023 | 9 | |
| 4 | 2022 | 6 | |
| 5 | 2021 | 2 | |
| 6 | 2021 | 2 | |
| 7 | 2020 | 2 | |
| 8 | 2020 | 1 | |
| 9 | 2020 | 11 | |
| 10 | 2019 | 5 | |
| 11 | 2019 | 4 | |
| 12 | 2017 | 65 | |
| 13 | 2017 | 5 | |
| 14 | 2017 | 50 | |
| 15 | 2016 | 28 | |
| 16 | 2016 | 8 | |
| 17 | 2016 | 30 | |
| 18 | 2015 | 41 | |
| 19 | 2015 | 10 | |
| 20 | 2012 | 107 |
About Patrick M. Dillon
Patrick M. Dillon is a scholar working on Oncology, Aging, Biological Psychiatry, Pulmonary and Respiratory Medicine and Internal Medicine, having authored 82 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (16 papers), Cancer Treatment and Pharmacology (13 papers), Advanced Breast Cancer Therapies (10 papers), HER2/EGFR in Cancer Research (9 papers), Brain Metastases and Treatment (8 papers), Palliative Care and End-of-Life Issues (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Cancer Diagnosis and Treatment (5 papers). The work is most often cited by research in Oncology (1.2k citations), Aging (38 citations), Immunology (389 citations), Biological Psychiatry (45 citations) and Cancer Research (247 citations). Patrick M. Dillon has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Christopher A. Moskaluk, Christopher Y. Thomas, Anne M. Mills, Erik Dill, Samhita Chakraborty, Timothy N. J. Bullock, Norman E. Sharpless, K. Lenhard Rudolph, Craig L. Slingluff and Chad Torrice. Their work appears in journals such as Journal of Clinical Oncology, Medical Oncology, Clinical Cancer Research, Journal of Neuro-Oncology and Critical Reviews in Oncology/Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.